Breaking
•Lavrov: EU trying to buy time for Kyiv with ceasefire bids - Breakingthenews.net•Real Madrid medical chief insists player health should take priority over football calendar: ‘We need to raise awareness’ - Yahoo Sports•DEP - Day 501: Pin Oak Energy Partners LLC Failed To Comply With Consent Order To Restore 2 Shale Gas Well Pads, Impoundment In Beaver County - PA Environment Digest Blog•China provides certainty for climate governance - China Daily Global Edition•LIFE Archiclima: making buildings ready for a changing climate - European Climate, Infrastructure and Environment Executive Agency•‘I still have those international days in me’: KS Bharat - The Indian Express•Cricket Australia CEO Todd Greenberg Rejects Fresh Sandpapergate Probe After Usman Khawaja Claims - NewsCord•Arsene Wenger Weighs Challenge to Infantino in 2027 FIFA Elections - beIN SPORTS•Victor Wembanyama’s latest feat comes down to a choice: ‘Have them meet me in the air’ - The New York Times•The Jags get aggressive, plus new CFP details - The New York Times•College football is over as you know it - Yahoo Sports•Barcelona defender Cubarsi named 2026 Golden Boy winner - Yahoo Sports•Chris sports and social - Nov. 9, 2026 - KSLA•Earnings call transcript: Medios posts steady Q3 2026 growth as margins narrow - Investing.com UK•SNFC: Life insurance sales climb while carrier earnings slide - Insurance Business•Pete Hegseth to hold news briefing as he faces possible impeachment – US politics live•Wisconsin senator calls out railroad CEO for threat to raise rates - The Business Journals•How UAE hotels are tackling guestroom waste through reuse and repair - Hotelier Middle East•Qatar says US and Iran have responded positively to mediation - Middle East Eye•Global Coalition of Leaders from Africa, Asia, and the Pacific Gathers to Endorse Global Rooftop Solar Declaration at COP31 - Frontier Africa Reports•Lavrov: EU trying to buy time for Kyiv with ceasefire bids - Breakingthenews.net•Real Madrid medical chief insists player health should take priority over football calendar: ‘We need to raise awareness’ - Yahoo Sports•DEP - Day 501: Pin Oak Energy Partners LLC Failed To Comply With Consent Order To Restore 2 Shale Gas Well Pads, Impoundment In Beaver County - PA Environment Digest Blog•China provides certainty for climate governance - China Daily Global Edition•LIFE Archiclima: making buildings ready for a changing climate - European Climate, Infrastructure and Environment Executive Agency•‘I still have those international days in me’: KS Bharat - The Indian Express•Cricket Australia CEO Todd Greenberg Rejects Fresh Sandpapergate Probe After Usman Khawaja Claims - NewsCord•Arsene Wenger Weighs Challenge to Infantino in 2027 FIFA Elections - beIN SPORTS•Victor Wembanyama’s latest feat comes down to a choice: ‘Have them meet me in the air’ - The New York Times•The Jags get aggressive, plus new CFP details - The New York Times•College football is over as you know it - Yahoo Sports•Barcelona defender Cubarsi named 2026 Golden Boy winner - Yahoo Sports•Chris sports and social - Nov. 9, 2026 - KSLA•Earnings call transcript: Medios posts steady Q3 2026 growth as margins narrow - Investing.com UK•SNFC: Life insurance sales climb while carrier earnings slide - Insurance Business•Pete Hegseth to hold news briefing as he faces possible impeachment – US politics live•Wisconsin senator calls out railroad CEO for threat to raise rates - The Business Journals•How UAE hotels are tackling guestroom waste through reuse and repair - Hotelier Middle East•Qatar says US and Iran have responded positively to mediation - Middle East Eye•Global Coalition of Leaders from Africa, Asia, and the Pacific Gathers to Endorse Global Rooftop Solar Declaration at COP31 - Frontier Africa Reports
TheNewsPulse.pro
Home/clinical trials/diseases/drugs
clinical_trials

Next-generation KRAS G12C inhibitor improves survival in lung cancer

Confidence95·multiple reportsImportance97NP-EVT-20261110-955E1F2

Nature Medicine, Published online: 10 November 2026; doi:10.1038/d41591-026-00057-9 Phase 3 trial data show that the next-generation KRAS G12C inhibitor divarasib leads to longer progression-free survival than the first-generation inhibitors sotorasib and adagrasib in patients with non–small-cell lung cancer.

Read the original at the primary source
Next-generation KRAS G12C inhibitor improves survival in lung cancer
11/10/2026, 12:00:00 AM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse

Discussion

ChatsPulse · 0 threads

No discussion yet. Sign in and start the first thread —